EpicentRx Receives Fast Track Designation from the U.S. FDA for Lead Asset, RRx-001, to Prevent/Attenuate Chemotherapy and Radiation Treatment Induced Severe Oral Mucositis

2023 APR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- EpicentRx, Inc. ('EpicentRx'), announced that the U.S. Food and Drug Administration (FDA) granted Fast [...]